1Hal DR,Odendao HJ,Kirsten GF,e t al.Expect ant managementof early onset,severe pre-eclampsia:perinatal outcome[J].Br JObstet Gynaecol,2000,107(10):1258-1264.
5Bolte AC, van Geijn HP, Dekker GA. Management and monitoring of severe preeelampsia [ J ]. Eur J Obstet Gynecol Reprod Bio1,2001,96( 1 ) :8-20.
6Sibai BM, Barton JR. Expectant management of severe preeclampsia remote from term : patient selection, treatment, and delivery indications [ J ]. Am J Obstet Gynecol, 2007,196 ( 6 ) : 514e1-9.
7Haddad B, Kayem G, Deis S, et al. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growtfi restriction? [ J]. Am J Obstet Gyneco1,2007,196 ( 3 ) :237el-5.
8Hall DR, Grov D, Carstens E. Early pre-eelampsia: what proportion of women qualify for expectant management and if not, why not? [ J]. Eur J Obstet Gynecol Reprod Biol,2006, 128( 1- 2) : 169-174.
9Bloomenthal D, yon Dadelszen P, Liston R. The effect of factor V Leiden carriage on maternal and fetal health [ J ]. CMAJ, 2002,167( 1 ) :48-54.
10Steyn DW, Odendaal H J, Hall DR. Diurinal blood pressure variation in the evaluation of early onset severe pre-eclampsia [ J ]. Eur J Obstet Gynecol Reprod Biol,2008,138 (2) :141-146.
8Kim YJ,Park HS,Lee HY.et al.Reduced L-arginine level and decreased placental eNOS activity in preeclampsia[J].Placenta,2006;27(4):438-444.
9Schiessl B,Mylonas l,Hantschm ann P, et al.Expression of endothelial NO synthase,inducible NO synthase,and estrogen receptors alpha and beta in placental tissue of normal preeclamptie and intrauterine growth restricted pregnaneies[J].J Histochem Cytochem,2005;53(12):1441.
10Bogdan C,Rollinghoff M,Diefenbach.Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity[J].Curr Opin Immunol,2000; 12( 1 ):64-76.
